AAV9.SLC6A1 Gene Therapy (Emily De Los Reyes)

N/A

Report date: 2025/09/17 20:01:18

Base Information

Drug NameAAV9.SLC6A1 Gene Therapy (Emily De Los Reyes)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV9 vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSLC6A1 Neurodevelopmental Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmily De Los Reyes
China Registration ClassN/A

Develop Information

Active CompaniesEmily De Los Reyes
Inactive CompaniesN/A
Active IndicationsSLC6A1 Neurodevelopmental Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A